Author: Dr Delwyn Dyall-Smith FACD, Dermatologist, 2011.
PFAPA is an acronym derived from periodic fever, aphthous stomatitis, pharnygitis and adenitis, the major features of this syndrome. It is the commonest cause of a recurrent fever syndrome in children.
PFAPA syndrome predominantly affects children, with onset in the first five years, and as young as 1 month of age (mean 18 months of age).
There is no correlation with race, sex or geographic area but it has mainly been reported from Europe and America.
No genetic defect for PFAPA syndrome has yet been determined, however 14% have a positive family history so there may be an as yet unidentified genetic basis for some cases.
PFAPA syndrome is a more common cause of recurrent fever in children than monogenic periodic fevers and the age at onset is generally older than for genetically positive patients with PFAPA-like symptoms.
A child with PFAPA syndrome presents with recurrent episodes every 2-6 weeks which, in 60%, occur with clockwork regularity. The episodes last for 3-6 days and there are symptom-free intervals of 3-5 weeks. Between episodes the child is well with normal growth and development.
The major feature of an episode is fever with spikes ranging 38.5-41C.
Spontaneous remission occurs in 30% with PFAPA syndrome after 4-8 years.
Diagnosis of PFAPA syndrome is clinical, with exclusion of other causes. It is based on recurrent fever of early onset (<5years) and at least one of the following associated features:
In the absence of:
There are no specific tests for PFAPA syndrome, but during a febrile attack, the following blood test abnormalities may be noted:
White cell count and acute phase reactants are normal when symptom-free.
In a study in Italy of 210 children fulfilling the criteria for PFAPA syndrome, 43 carried diagnostic mutations for a familial fever syndrome – mevalonate kinase deficiency (33), familial Mediteranean fever (7) and TRAPS (3). The Gaslini score is useful for identifying patients who fit the PFAPA syndrome criteria and who are at low risk of carrying a mutation associated with a monogenic periodic fever.
The Gaslini score is calculated from:
Patients with a low-risk Gaslini score may be diagnosed as having PFAPA syndrome without having genetic testing. However those with a high risk score should be screened for the most likely gene depending on clinical and laboratory findings and classified as PFAPA syndrome only after negative genetic testing.
Options to treat PFAPA syndrome include:
See the DermNet NZ bookstore
© 2018 DermNet New Zealand Trust.
DermNet NZ does not provide an online consultation service. If you have any concerns with your skin or its treatment, see a dermatologist for advice.